Retatrutide vs Ozempic in UAE: Which GLP-1 Delivers Better Weight Loss?
Retatrutide vs Ozempic in UAE: Which GLP-1 Delivers Better Weight Loss?
- Retatrutide: 24.2% weight loss in 48 weeks — Ozempic: ~15% in 68 weeks
- Retatrutide is a triple agonist; Ozempic is a single GLP-1 agonist
- Ozempic has faced supply shortages in UAE pharmacies since 2023
- Ozempic: AED 740–1,100 per pen in UAE; retatrutide research compound available at Core Sup
- Retatrutide is appropriate for Ozempic users who have plateaued or want faster, deeper weight loss
Ozempic changed how the world thinks about weight loss. When semaglutide arrived in UAE pharmacies, it delivered results that diet and lifestyle alone rarely achieved. But its single GLP-1 mechanism has a ceiling — most users plateau at 12–15% body weight reduction. Retatrutide, with its triple receptor mechanism, shatters that ceiling. This guide compares both compounds head-to-head for UAE buyers using verified clinical trial data.
How the Mechanisms Differ
Ozempic (semaglutide) is a GLP-1 receptor agonist — it mimics a naturally occurring hormone that slows gastric emptying and signals fullness to the brain. This reduces calorie intake, which over 68 weeks produces around 15% body weight loss at the 2mg dose. Ozempic is FDA approved for type 2 diabetes (as Ozempic) and weight management (as Wegovy, a higher-dose version).
Retatrutide does everything Ozempic does through GLP-1 — and then adds two more mechanisms. GIP receptor activation improves how fat tissue responds to insulin and how calories from food are handled. Glucagon receptor activation increases energy expenditure by stimulating the liver and driving fat oxidation. The result is a compound that reduces intake, improves metabolic handling, and burns more calories simultaneously — producing weight loss that Ozempic's single mechanism cannot approach.
Clinical Trial Results: The Evidence
| Compound | Trial | Max Dose | Duration | Average Weight Loss |
|---|---|---|---|---|
| Ozempic (semaglutide) | STEP-1 | 2.4mg/week | 68 weeks | ~14.9% |
| Ozempic (semaglutide) | STEP-2 (T2D) | 2.4mg/week | 68 weeks | ~9.6% |
| Retatrutide | TRIUMPH Phase 2 | 4mg/week | 48 weeks | ~17.3% |
| Retatrutide | TRIUMPH Phase 2 | 8mg/week | 48 weeks | ~22.8% |
| Retatrutide | TRIUMPH Phase 2 | 12mg/week | 48 weeks | ~24.2% |
Even retatrutide at 4mg/week (17.3% in 48 weeks) outperforms Ozempic at its maximum dose (14.9% in 68 weeks) — in 20 fewer weeks.
Ozempic Availability Issues in UAE: A Real Problem
Retatrutide, as a research compound supplied through specialist channels like Core Sup, does not face these same supply constraints. UAE buyers can order and receive consistent supply without the pharmacy stock uncertainty that affects Ozempic availability.
Price Comparison in UAE
| Product | UAE Price | Supply | Available at Core Sup? |
|---|---|---|---|
| Ozempic 0.25mg/0.5mg pen | ~AED 740/pen | Variable (shortage) | No |
| Ozempic 1mg pen | ~AED 1,000–1,100/pen | Variable (shortage) | No |
| Retatrutide 5mg vial | USD equivalent ~450–600 AED | Consistent | Yes |
| Retatrutide 10mg vial | USD equivalent ~600–900 AED | Consistent | Yes |
Side Effects: Ozempic vs Retatrutide in Practice
Both compounds are GLP-1 agonists and share similar side effect profiles. The differences in practice:
| Side Effect | Ozempic | Retatrutide |
|---|---|---|
| Nausea (initial) | Common — typically fades within 4–8 weeks | Common at higher doses — requires gradual titration |
| Appetite suppression | Moderate — reliable and consistent | Strong — more pronounced than Ozempic |
| Energy level | Neutral or slight fatigue in some | May produce mild energy increase (glucagon effect) |
| Plateau | Most users plateau at 12–15% loss | Less plateau observed at higher doses in trials |
| GI discomfort | Mild-moderate, dose dependent | Moderate — managed with dose escalation protocol |
Who Should Stay on Ozempic?
- Users with type 2 diabetes who need an FDA-approved, prescribed medication
- Those who have achieved satisfactory weight loss (10–15%) and do not need to go further
- Individuals who prefer the simplicity of a pre-filled pen with no reconstitution
- Those whose physician manages their dose and prefers approved medications
Who Should Consider Switching to Retatrutide?
- Ozempic non-responders — those who lost less than 5% body weight after 12 weeks on Ozempic
- Plateau users — those who lost 10–15% and have stopped losing despite maximum Ozempic dosing
- Supply-frustrated UAE buyers — those who cannot reliably obtain Ozempic through UAE pharmacies
- Those targeting 20%+ weight loss — a goal that Ozempic's single-receptor mechanism rarely achieves
- Cost-conscious buyers — retatrutide's research compound pricing is competitive for the UAE market
Verdict for UAE Buyers
Ozempic was the right answer in 2022. In 2026, retatrutide delivers superior results, consistent supply, and better value for UAE buyers who are ready to go beyond what Ozempic offers. The 60% greater weight loss in a shorter timeframe is not a marginal difference — it is a fundamentally different outcome for people with significant weight to lose.
How to Switch from Ozempic to Retatrutide
- Take your final Ozempic dose as normal
- Wait 7 days (one standard dosing interval)
- Begin retatrutide at 2mg/week — do not start at a higher dose assuming Ozempic tolerance transfers
- Follow the standard 4-week escalation protocol: 2mg → 4mg → 6mg → 8mg
- See our full Retatrutide Dosage Protocol UAE Guide for week-by-week instructions
Ready to Upgrade from Ozempic? Retatrutide at Core Sup — UAE Delivery
Third-party tested. Batch CoA provided. Same-day delivery to Dubai. WhatsApp: +447380308001.
Buy Retatrutide at Core SupRelated Guides
- Where to Buy Retatrutide in Dubai and UAE
- Retatrutide Dosage Protocol UAE (2026)
- Retatrutide vs Mounjaro in UAE
- Retatrutide vs Tirzepatide vs Semaglutide: Full Comparison
- Retatrutide Side Effects Guide
